Voyager Therapeutics | SCHEDULE 13G/A:其他
Voyager Therapeutics | 4:持股变动声明-高管 Carter Todd Alfred
Voyager Therapeutics | 4:持股变动声明-高管 Swartz Robin
Voyager Therapeutics | 4:持股变动声明-高管 Fahey Sandell Jacquelyn
Voyager Therapeutics | 4:持股变动声明-高管 Sandrock Alfred
Voyager Therapeutics | 144:拟议出售证券
Voyager Therapeutics | 144:拟议出售证券
Voyager Therapeutics | 144:拟议出售证券
Voyager Therapeutics | 144:拟议出售证券
Voyager Therapeutics | 8-K:重大事件
Voyager Therapeutics | 4:持股变动声明-高管 Swartz Robin
Voyager Therapeutics | 4:持股变动声明-高管 Carter Todd Alfred
Voyager Therapeutics | 144:拟议出售证券
Voyager Therapeutics | 144:拟议出售证券
Voyager Therapeutics | 4:持股变动声明-高管 Swartz Robin
Voyager Therapeutics | 144:拟议出售证券
Voyager Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(9.99%),Oleg Nodelman(9.99%)等
Voyager Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(9.54%),Steven Boyd(9.54%)
Voyager Therapeutics | 10-Q:2024财年三季报
Voyager Therapeutics | 8-K:旅行者公布2024年第三季度财务和经营业绩